Millet-based Muffins, Glycaemic Response, Insulinemic Response and Gastric Emptying
The Effect of Millet-based Muffins on Glycaemic, Insulinemic Response and Gastric Emptying in Pre-diabetic Adults
1 other identifier
interventional
30
1 country
1
Brief Summary
Millet is a functional grain that has attracted the attention of scientists for many years due to its significant benefits to human health. Research has shown that millets have a high antioxidant capacity and polyphenol content which can contribute to a reduced risk of some chronic diseases such as type 2 diabetes and its complications. This study aimed to assess the glycaemic response (GR), insulinaemic response (IR) and gastric emptying (GE) after the consumption of millet-based muffins in pre-diabetic and healthy participants. This was a single-blind, randomized controlled crossover study in which participants consumed one control muffin (wheat) and one test muffin (millet). During each session, participants were required to consume either the test or the control muffin, consuming the alternative on the next visit. Then, 10 finger-prick blood samples were taken for the determination of glucose and insulin over 4 hours. 13Carbon (13C) sodium acetate was added to the muffins (control and test) in order to measure gastric emptying from the breath samples collected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Mar 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 6, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 24, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 24, 2017
CompletedFirst Submitted
Initial submission to the registry
October 11, 2020
CompletedFirst Posted
Study publicly available on registry
October 23, 2020
CompletedOctober 23, 2020
October 1, 2020
10 months
October 11, 2020
October 17, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Change in glycaemic response from baseline for 180 minutes
Capillary blood glucose was measured for 180 minutes at 0, 15, 30, 45, 60, 90, 120, 150 and 180 minutes
180 minutes
Change in insulin response from baseline for 180 minutes
Capillary plasma insulin was measured for 180 minutes at 0, 15, 30, 45, 60, 90, 120, 150 and 180 minutes
180 minutes
Secondary Outcomes (2)
Gastric emptying for 4 hours
4 hours
Satiety by visual analogue scale for 4 hours
4hours
Study Arms (2)
Wheat muffin
PLACEBO COMPARATORMuffin made with 100% wheat flour
Finger millet grain muffin
EXPERIMENTALMuffin made with 50% wheat flour and 50% finger millet crushed grain
Interventions
Participants consumed a test muffin made of finger millet grain and wheat flour.
Eligibility Criteria
You may qualify if:
- for healthy participants
- Aged 18-65 years
- Body mass index (BMI) ≤ 30kg/m2
- Fasting blood glucose \< 6.1 mmol/l
- Non-pregnant and non-lactating
- No known diabetes or impaired glucose tolerance
- No medical condition(s) or medication(s) known to affect glucose regulation or appetite and/or which influence digestion and absorption of nutrients
- No major medical or surgical event requiring hospitalisation within the preceding three months
- No use of steroids, protease inhibitors or antipsychotics
- No food allergy to millet, wheat, egg and milk.
- At least one of the following for pre-diabetes participants Fasting blood glucose 6.1-6.9 mmol/l (108-125 mg/ dI) - (WHO, 2006) or/and an Oral glucose tolerance test (OGTT) at 2 hours 7.9 to 11.0 mmol/l
You may not qualify if:
- Pregnant and lactating
- Diabetes
- Medical condition(s) or medication(s) known to affect glucose regulation or appetite and/or which influence digestion and absorption of nutrients
- Medical or surgical event requiring hospitalisation within the preceding three months
- Use of steroids, protease inhibitors or antipsychotics (because of their effects on glucose regulation of appetite or influence digestion and absorption of nutrients).
- Food allergy to study products (millet. wheat, egg, milk, butter, sugar).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oxford Brookes Universitylead
- Taibah Universitycollaborator
Study Sites (1)
Oxford Brookes Centre for Nutrition and Health
Oxford, OX3 0BP, United Kingdom
Related Publications (2)
Brouns F, Bjorck I, Frayn KN, Gibbs AL, Lang V, Slama G, Wolever TM. Glycaemic index methodology. Nutr Res Rev. 2005 Jun;18(1):145-71. doi: 10.1079/NRR2005100.
PMID: 19079901BACKGROUNDCarbohydrates in human nutrition. Report of a Joint FAO/WHO Expert Consultation. FAO Food Nutr Pap. 1998;66:1-140. No abstract available.
PMID: 9743703BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sangeetha Thondre
Oxford Brookes University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Lecturer
Study Record Dates
First Submitted
October 11, 2020
First Posted
October 23, 2020
Study Start
March 6, 2017
Primary Completion
December 24, 2017
Study Completion
December 24, 2017
Last Updated
October 23, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Immediately following registration
- Access Criteria
- Upon request